ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,338,811 | +2.8% | 43,752 | -14.7% | 0.04% | 0.0% |
| Q1 2023 | $1,302,309 | -36.9% | 51,272 | +0.7% | 0.04% | -39.0% |
| Q4 2022 | $2,064,504 | +48.1% | 50,900 | +20.7% | 0.06% | +28.3% |
| Q3 2022 | $1,394,000 | -20.8% | 42,176 | -15.6% | 0.05% | -9.8% |
| Q2 2022 | $1,760,000 | -26.2% | 49,998 | -3.6% | 0.05% | +6.2% |
| Q1 2022 | $2,384,000 | +69.7% | 51,844 | +144.7% | 0.05% | +77.8% |
| Q4 2021 | $1,405,000 | -15.3% | 21,190 | -20.3% | 0.03% | -35.7% |
| Q3 2021 | $1,659,000 | -5.5% | 26,575 | +25.3% | 0.04% | -25.0% |
| Q2 2021 | $1,756,000 | +14.8% | 21,203 | -8.1% | 0.06% | -1.8% |
| Q1 2021 | $1,530,000 | – | 23,068 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |